May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!
Proteomic and Metabolic Plasma iCPET Studies By Ronald G.Tompkins, MD, ScD We have received an anonymous grant of $350,000 designated for the “Proteomic and Metabolomic
The goal of this study was to extend the Severely ill Patient Study and conduct a comprehensive “Big Data” analysis on ME/CFS patients and their families.
The study’s objective was to establish the role of T cells and the immune system in ME/CFS by examining the genetic material in T cells — immune cells that identify and kill infected cells.
The goal of the Severely ill Patient Study was to conduct a comprehensive “Big Data” analysis on severely ill ME/CFS patients in order to begin an exploration to find the molecular basis of ME/CFS.
The aim of this study was to test the hypothesis developed by Dr. Phair that a crucial component of metabolism in ME/CFS patients appears to be “trapped” in an unhealthy state.
The newest OMF-funded ME / CFS Collaborative Research Center is at Uppsala University in Sweden. Led by Jonas Bergquist, MD, PhD, the Center is working in collaboration
OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo
Copyright © 2025 Open Medicine Foundation. All Rights Reserved.
